NEW YORK (TheStreet) --One of the most exciting weeks on Wall Street has officially come to a close. In the past week, America elected its 45th President, political outsider Donald Trump, markets plummeted when it appeared he would be the victor, but then skyrocketed once the results were final.

The Dow Jones Industrial Average completed its best week in five years, up 5%, and eclipsing an all-time closing high today.

The S&P 500 also performed well this week, despite closing lower today. And the NASDAQ, seen as the laggard of the post-election rally, closed in the green.

Additionally, the Russell 2000 is up 10% in the past six trading sessions. "Generally higher interest rates are a tougher job for small-caps, but if you get growth along with it, small caps tend to outperform big caps," CNBC's Bob Pisani said on today's "Closing Bell."

The 10-Year Treasury Note has also been surging since Wednesday.

"It's interesting because we already have the Fed primed to do something, and this is perfect for them. Fiscal stimulus, they've been asking for it for ages. Finally, they've got some. Perfect cover for them," Pisani noted.

Regarding sectors, Pisani explained the biggest winners during the post-election rally.

"Banks, pharmaceuticals, industrial's; banks and pharmaceuticals moving up on lower regulations, industrial's moving up on the hope of stimulus and infrastructure plans," he said.

Now, we have somewhat seen the momentum stalled a bit, and Pisani noted that centers around some Trump uncertainty regarding policy.

"We need more details about what's going to happen. We need specifics; the Cabinet appointments in a couple of weeks may be the start of speculating what might happen," Pisani suggested. 

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing